PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET
|
|
- Judith Daniel
- 5 years ago
- Views:
Transcription
1 BIOVETA, a. s. Komenského 212, Ivanovice na Hané, Czech Republic, PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET
2 SUMMARY OF PRODUCT CHARACTERISTICS
3 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioBos Respi 3 suspension for injection for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vaccination dose (2 ml) contains: Active substances: Bovine respiratory syncytial virus (BRSV) inactivated, strain BIO-24 RP 1* Bovine parainfluenza 3 virus inactivated (PI3V), strain BIO-23 RP 1* Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1 RP 1* * RP = Relative potency (ELISA) in comparison with the reference serum obtained after vaccination of guinea pigs with a vaccine batch that has successfully passed the challenge test in the target animals. Adjuvants: Aluminium hydroxide hydrated for adsorption Quillaja saponin (Quil A) 8.0 mg 0.4 mg Excipients: Thiomersal Formaldehyde 35% solution 0.2 mg max. 1 mg For the full list of excipients, see section PHARMACEUTICAL FORM Suspension for injection. Rosy liquid with sediment. 4. CLINICAL PARTICULARS 4.1 Target species Cattle. 4.2 Indications for use, specifying the target species For active immunisation of cattle against: - bovine parainfluenza 3 virus, to reduce infection, - bovine respiratory syntytial virus, to reduce infection and clinical signs, - germs of Mannheimia (Pasteurella) haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity: 3 weeks Duration of immunity: 6 months Safety and efficacy studies were performed in sero-negative calves. 4.3 Contraindications
4 Do not use in cases of hypersensitivity to the active substances, to the adjuvants or to any of the excipients. 4.4 Special warnings for each target species Vaccinate healthy animals only. 4.5 Special precautions for use Special precautions for use in animals: Basic immunisation needs to be initiated on time, so that the protection is fully developed from the beginning of the risky period of the animal. Basic immunisation of calves needs to be completed before common stabling or during quarantine. It is recommended to vaccinate all animals in the breed, if vaccination is not contraindicated in some animals, so that the infectious burden was minimised. Failure to vaccinate each animal helps to maintain and transfer pathogens and development of the disease in the breed. The level of antibody responses may be reduced by maternal antibodies obtained from the mothers in calves up to 3 months of age. Respiratory infections in calves are often associated with poor hygiene practices. Therefore general enhancement of hygiene practices is important to ensure good immunisation effect in vaccinated animals. Special precautions to be taken by the person administering the veterinary medicinal product to animals: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. 4.6 Adverse reactions (frequency and seriousness) Following vaccination a localised swelling may be observed very commonly at the injection site which relates to the adjuvant content. This swelling could reach up to 6 cm and usually subsides within 2 3 weeks after vaccination. There may be a common transient slight increase in body temperature lasting up to 3 days after vaccination. Anaphylactic-type reactions may occur very rarely after vaccination. In such cases, appropriate symptomatic treatment should be administered. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports) 4.7 Use during pregnancy, lactation or lay Do not use during pregnancy and lactation. 4.8 Interaction with other medicinal products and other forms of interaction No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. 4.9 Amounts to be administered and administration route
5 Vaccine dose 2 ml The vaccine is administered subcutaneously. Heat up the vaccine before use to a temperature of 15 to 25 C and shake the content of the vial. Basic immunisation: Calves from non-immune dams: 2 injections 3 weeks apart from 2 weeks of age Calves from immune dams: 2 injections 3 weeks apart from 3 months of age Revaccination: In problematic breeds, another revaccination is recommended within a period of 6 months after basic immunisation, possibly before risky period in particular breed (e.g. transfer of animals, change of the stabling system, etc.) Overdose (symptoms, emergency procedures, antidotes), if necessary No other adverse effects than those mentioned under section 4.6 (Adverse reactions) have been observed after administration of an overdose of the vaccine. Local reactions after subcutaneous administration of high dose were higher (up to 9 cm in diameter) than after standard dose Withdrawal periods Zero days. 5. IMMUNOLOGICAL PROPERTIES Pharmacotherapeutic group: Immunologicals for cattle; inactivated viral and bacterial vaccines. ATCvet code: QI02AL04 The vaccine is intended for active immunisation of cattle against bovine respiratory syntitial virus, parainfluenza 3 virus and germs of Mannheimia (Pasteurella) haemolytica. 6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Aluminium hydroxide hydrated for adsorption Thiomersal Formaldehyde 35% solution Quillaja saponin (Quil A) Water for injection Natrium chloride 6.2 Major incompatibilities Do not mix with any other veterinary medicinal product. 6.3 Shelf life Shelf-life of the veterinary medicinal product as packaged for sale: 2 years Shelf-life after first opening the immediate packaging: 10 hours Special precautions for storage Store in a refrigerator (2 C 8 C). Protect from frost
6 Protect from light. 6.5 Nature and composition of immediate packaging The vaccine is filled to glass vials: hydrolytic class I: 10 ml vials containing 10 ml (5 doses) hydrolytic class II: 50 ml vials containing 50 ml (25 doses), 100 ml vials containing 100 ml (50 doses) And to plastic vials: 15 ml vials containing 10 ml (5 doses), 60 ml vials containing 50 ml (25 doses), 120 ml vials containing 100 ml (50 doses) All types of vials are closed with rubber chlorobutyl stopper and secured with aluminium seal. The product is delivered in the following pack size: a/ plastic box with a cover, with 10 cavities 10 x 10 ml b/ cardboard box: 1 x 10 ml, 1 x 50 ml, 1 x 100 ml c/ carton for mass packaging 10 x 10 ml Each package contains an approved "Package leaflet. Not all pack sizes may be marketed. 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. 7. MARKETING AUTHORISATION HOLDER Bioveta, a. s. Komenského 212/ Ivanovice na Hané Czech Republic 8. MARKETING AUTHORISATION NUMBER 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 10 DATE OF REVISION OF THE TEXT PROHIBITION OF SALE, SUPPLY AND/OR USE Not applicable.
7 LABELLING AND PACKAGE LEAFLET
8 A. LABELLING
9 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE 1x10 ml, 10x10ml, 1x50 ml, 1x100 ml/ cardboard box 10x10 ml / covered plastic box with 10 cavities: label /shawl etiquette 50ml, 100ml / etiquette} 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioBos Respi 3 suspension for injection for cattle 2. STATEMENT OF ACTIVE SUBSTANCES Each vaccination dose (2 ml) contains: Active substances: Bovine respiratory syncytial virus (BRSV) inactivated, strain BIO-24 RP 1* Bovine parainfluenza virus (PI3V) inactivated, strain BIO-23 RP 1* Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1 RP 1* * RP = Relative potency (ELISA) in comparison with the reference serum obtained after vaccination of guinea pigs with a vaccine batch that has successfully passed the challenge test in the target animals. 3. PHARMACEUTICAL FORM Suspension for injection. 4. PACKAGE SIZE 1x10 ml, 10x10 ml 1x50 ml, 1x100 ml <50 ml, 100 ml - etiquette> 5. TARGET SPECIES Cattle. 6. INDICATION(S) 7. METHOD AND ROUTE(S) OF ADMINISTRATION Subcutaneous use. Read the package leaflet before use. 8. WITHDRAWAL PERIOD Withdrawal period: Zero days.
10 9. SPECIAL WARNING(S), IF NECESSARY Read the package leaflet before use. 10. EXPIRY DATE EXP: Once opened use by10 hours. 11. SPECIAL STORAGE CONDITIONS Store in a refrigerator. Protect from frost. Protect from light SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY Disposal: read package leaflet. 13. THE WORDS FOR ANIMAL TREATMENT ONLY AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE For animal treatment only. To be supplied only on veterinary prescription. 14. THE WORDS KEEP OUT OF THE SIGHT AND REACH OF CHILDREN Keep out of the sight and reach of children. 15. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Bioveta, a. s., Komenského 212/12, Ivanovice na Hané, Czech Republic 16. MARKETING AUTHORISATION NUMBER(S) 17. MANUFACTURER S BATCH NUMBER Batch:
11 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS {10 ml /etiquette} 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioBos Respi 3 suspension for injection for cattle 2. QUANTITY OF THE ACTIVE SUBSTANCE(S) Each vaccination dose (2 ml) contains: Active substances: Bovine respiratory syncytial virus (BRSV) inactivated, strain BIO-24 RP 1 Bovine parainfluenza 3 virus (PI3V) inactivated, strain BIO-23 RP 1 Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1 RP 1 3. CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES 10 ml 4. ROUTE(S) OF ADMINISTRATION Subcutaneous use. 5. WITHDRAWAL PERIOD Withdrawal period: Zero days. 6. BATCH NUMBER Batch {number} 7. EXPIRY DATE EXP {month/year} Once opened use by 10 hours. 8. THE WORDS FOR ANIMAL TREATMENT ONLY For animal treatment only.
12 B. PACKAGE LEAFLET
13 PACKAGE LEAFLET: BioBos Respi 3 suspension for injection for cattle 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorization holder and manufacturer responsible for batch release: Bioveta, a. s., Komenského 212/12, Ivanovice na Hané, Czech Republic 2. NAME OF THE VETERINARY MEDICINAL PRODUCT BioBos Respi 3 suspension for injection for cattle 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each vaccination dose (2 ml) contains: Active substances: Bovine respiratory syncytial virus (BRSV) inactivated, strain BIO-24 RP 1* Bovine parainfluenza 3 virus (PI3V) inactivated, strain BIO-23 RP 1* Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype 1A RP 1* * RP = Relative potency (ELISA) in comparison with the reference serum obtained after vaccination of guinea pigs with a vaccine batch that has successfully passed the challenge test in the target animals. Adjuvants: Aluminium hydroxide hydrated for adsorption Quillaja saponin (Quil A) Excipients: Thiomersal Formaldehyde 35% solution 8.0 mg 0.4 mg 0.2 mg max. 1 mg Pinkish liquid with sediment. 4. INDICATION For active immunisation of cattle against: - bovine parainfluenza 3 virus, to reduce infection, - bovine respiratory syntytial virus, to reduce infection and clinical signs, - germs of Mannheimia (Pasteurella) haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity: 3 weeks Duration of immunity: 6 months
14 Safety and efficacy studies were performed in sero-negative calves. 5. CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substances, to the adjuvants or to any of the excipients. 6. ADVERSE REACTIONS Following vaccination a localised swelling may be observed very commonly at the injection site which relates to the adjuvant content. This swelling could reach up to 6 cm and usually subsides within 2 3 weeks after vaccination. There may be a common transient slight increase in body temperature lasting up to 3 days after vaccination. Anaphylactic-type reactions may occur very rarely after vaccination. In such cases, appropriate symptomatic treatment should be administered. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports) If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. 7. TARGET SPECIES Cattle. 8. DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION Vaccine dose 2 ml The vaccine is administered subcutaneously. Basic immunisation: Calves from non-immune dams: 2 injections 3 weeks apart from 2 weeks of age Calves from immune dams: 2 injections 3 weeks apart from 3 months of age Revaccination: In problematic breeds, another revaccination is recommended within a period of 6 months after basic immunisation, possibly before risky period in particular breed (e.g. transfer of animals, change of the stabling system, etc.). 9. ADVICE ON CORRECT ADMINISTRATION Heat up the vaccine before use to a temperature of 15 to 25 C and shake the content of the vial. Vaccinate only healthy animals. 10. WITHDRAWAL PERIOD
15 Zero days. 11. SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children. Store in a refrigerator (2 C 8 C). Protect from frost. Protect from light. Do not use this this veterinary medicinal product after the expiry date which is stated on the label. Shelf-life after first opening the immediate packaging: 10 hours. 12. SPECIAL WARNINGS Special precautions for use in animals: The basic immunization should be started in time so that the protection has been fully developed until the start of animals risk period. The basic immunization of calves must be finished before their joint stabling or during quarantine. It is recommended to vaccinate all animals in the herd, unless the vaccination is contraindicated in some animals, to minimize the infection stress. Omission of individual animals helps preserve and transfer pathogens and develop the disease in the herd. The level of antibody responses may be reduced by maternal antibodies obtained from the mothers in calves up to 3 months of age. Respiratory infections in calves are often connected with a poor hygiene practices. Therefore, the total improvement of hygiene practices is important for ensuring a good immunization effect in vaccinated animals. Special precautions to be taken by the person administering the veterinary medicinal product to animals: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Use during pregnancy, lactation: Do not use during pregnancy and lactation. Interaction with other medicinal products and other forms of interaction: No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. Overdose (symptoms, emergency procedures, antidotes): No undesirable effects except those mentioned under section 6. (Adverse reactions) were observed. The local reactions after subcutaneous administration of excessive dose were larger (up to 9 cm in diameter) than after a standard dose. Incompatibilities: Do not mix with any other veterinary medicinal product. 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY
16 Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED 15. OTHER INFORMATION The vaccine is filled in glass vials of hydrolytic class I or II and plastic vials compliant with Ph.Eur., closed with rubber chlorobutyl puncturable stopper, secured with aluminium seal. Pack size: 1 x 10 ml, 10 x 10 ml 1 x 50 ml, 1 x 100 ml Not all pack sizes may be marketed.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval 3 BRSV Pi3 BVD Lyophilisate and suspension for suspension for injection for cattle 2. QUALITATIVE AND QUANTITATIVE
More informationBovine Herpes Virus type 1 (BoHV-1), strain Difivac (ge-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Inactivated 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (2ml) contains Active Substance: Bovine Herpes Virus type 1 (BoHV-1), strain
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioEquin H, emulsion for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vaccine dose (1 ml) contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RESPIPORC FLUpan H1N1 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican DAPPi lyophilisate and solvent for suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bovela lyophilisate and solvent for suspension for injection for cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4 suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn M.hyo - Parasuis, suspension for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: per 2 ml dose Inactivated Mycoplasma
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV M Hyo emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 2 ml contains: Active
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ingelvac CircoFLEX suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1 ml)
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Ducat (DE: Nobivac RC, SE : Nobivac Ducat vet.) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Per
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax Rabies suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Proteq West Nile suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4, suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn PCV suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BIOCOM P Vet, suspension for injection for minks (all MS except DK) BIOVAC-BP, suspension for injection for minks (DK) 2.
More informationB. PACKAGE LEAFLET 1
B. PACKAGE LEAFLET 1 PACKAGE LEAFLET BioEquin H, emulsion for injection for horses 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR suspension for injection for sheep and cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis OR inac emulsion for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.25
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Myxo-RHD lyophilisate and solvent for suspension for injection for rabbits 2. QUALITATIVE AND QUANTITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Circovac emulsion and suspension for emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle Rispoval IBR-Marker Live (for
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu-Te Suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Piro lyophilisate and solvent for suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis Prequenza suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis Influenza H5N2 emulsion for injection for chickens. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT VANGUARD CPV-L 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Quantity per 1 ml dose Active substance(s): Live attenuated canine Parvovirus, strain NL-35-D, low passage,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis Pesti emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP FeLV lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains: Active substance: Inactivated feline leukaemia
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Coliprotec F4/F18 lyophilisate for oral suspension for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Part I.B page 1 of 7 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/7 Part I.B page 2 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE
More informationPaul-Ehrlich-Institut
Paul-Ehrlich-Institut DE/V/0021/001/II/014 Page 1 Paul-Ehrlich-Institut Federal Institute for Vaccines and Biomedicines FINALISATION REPORT ON VARIATION TYPE II PRODUCT DETAILS Name of products Active
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican DHPPi 2 -L multi Lyophilisate and suspension for suspension for injection. (for Bulgaria, Croatia, Cyprus,
More informationInstitute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv
Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Hudcova 56
More information1. NAME OF THE VETERINARY MEDICINAL PRODUCT. ALPHA JECT micro 6 emulsion for injection for Atlantic salmon 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1. NAME OF THE VETERINARY MEDICINAL PRODUCT ALPHA JECT micro 6 emulsion for injection for Atlantic salmon 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance(s): 1 dose (0.05 ml) contains: Formaldehyde
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AFTOVAXPUR DOE emulsion for injection for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equilis StrepE, lyophilisate and solvent for suspension for injection, for horses 2. QUALITATIVE AND QUANTITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RHINISENG suspension for injection for pigs. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ERYSENG PARVO suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equip WNV emulsion for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationPaul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1
Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1 PACKAGE LEAFLET Rispoval IBR-Marker Vivum Lyophilisate and diluent for suspension for injection for cattle. 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Versican Plus L4 suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MS-H Vaccine eye drops suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: One dose (30 µl)
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB Primo QX lyophilisate and solvent for suspension for chickens Nobilis IB Primo QX lyophilisate for suspension
More information[Version 8, 10/2012] ANNEX I SUMMARY OF PROPOSED PRODUCT CHARACTERISTICS
[Version 8, 10/2012] ANNEX I SUMMARY OF PROPOSED PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Uniferon 200 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ERAVAC emulsion for injection for rabbits 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ZULVAC 8 Ovis suspension for injection for sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml of
More informationLeptospirosis has changed. Here's how to meet the new threat
Leptospirosis has changed. Here's how to meet the new threat Introducing Nobivac L 4 The UK s first tetravalent leptospirosis vaccine Serovars identified by positive MAT test results* from clinical submissions
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB 4-91 lyophilisate for suspension for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of
More informationENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS
ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENCEFAL-VAC Live lyophilised vaccine for chickens 2. QUALITATIVE AND QUANTITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT INCURIN 1 mg tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
More informationRotavec Corona Emulsion for injection for cattle. Introduction. Company name: MSD Animal Health. Address: Walton Manor. Walton. Milton Keynes MK7 7AJ
Rotavec Corona Emulsion for injection for cattle Introduction Company name: MSD Animal Health Address: Walton Manor Walton Milton Keynes MK7 7AJ Telephone: 01908 685685 (Customer Support Centre) Fax: 01908
More informationBuserelin animedica mg/ml Injektionslösung für Rinder, Pferde, Kaninchen
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Buserelin animedica 0,004 mg/ml Injektionslösung für Rinder, Pferde, Kaninchen (Germany) Buserelin animedica 0.004 mg/ml Injektionslösung für Rinder, Pferde,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CZ, Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle (AT, BE, DE, DK, ES, HU, IE, IT, NL, PL,
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Procycline LA 200 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substance Oxytetracycline (as dihydrate) 200.0
More informationSummary of Product Characteristics
Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Novamune concentrate and solvent for suspension for injection for chickens 2 QUALITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT HIPRABOVIS IBR MARKER LIVE lyophilisate and solvent for suspension for injection for cattle. 2. QUALITATIVE AND
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Canigen L4 suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AviProSALMONELLA VAC E Lyophilisate for suspension for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis ND Clone 30 live 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: per dose * Live Newcastle disease virus, strain Clone 30 ³ 6.0 log 10 ELD
More informationBeurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Versican L3R. Zulassungsdatum:
Beurteilungsbericht zur Veröffentlichung (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Versican L3R Zulassungsdatum: 21.02.2012 Zulassungsnummer: PEI.V.11603.01.1 Datum der Erstellung des öffentlichen Beurteilungsberichts:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Semintra 4 mg/ml oral solution for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active substance:
More informationInstitute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv
Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Hudcova 56
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Credelio 56 mg chewable tablets for dogs (1.3 2.5 kg) Credelio 112 mg chewable tablets for dogs (>2.5 5.5 kg) Credelio
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DUPHALYTE Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Composition per ml VITAMINS
More informationANNEX III LABELLING AND PACKAGE LEAFLET
ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Outer carton Multi-pack 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Fevaxyn Pentofel, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml
More information[Version 8.1, 01/2017] ANNEX I. SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8.1, 01/2017] ANNEX I. SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis SE live lyophilisate for use in drinking water for chickens 2. QUALITATIVE AND QUANTITATIVE
More informationBeurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Versifel FeLV. Zulassungsdatum:
Beurteilungsbericht zur Veröffentlichung (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Zulassungsdatum: 19.11.2010 Zulassungsnummer: PEI.V.11457.01.1 Datum der Erstellung des öffentlichen Beurteilungsberichts:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 50 mg/ml solution for injection for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PT, RO,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Versican Plus DHPPi/L4 lyophilisate and solvent for suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE
More informationPART 1.B SPC, LABELLING AND PACKAGE LEAFLET
TRAMADOG, solution for injection Decentralised Procedure D195 February 2018 V3 Tramadol HCl 50 mg/ml Part 1.B SPC, Labelling and Package Leaflet PART 1.B SPC, LABELLING AND PACKAGE LEAFLET 1B- 1 ANNEX
More informationADT Booster Data Sheet
1. PRODUCT NAME ADT Booster. Diphtheria and Tetanus Vaccine (adsorbed) for revaccination. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ADT Booster is a suspension for intramuscular injection, containing
More informationInstitute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv
Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Hudcova 56
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Revised: October 2010 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Caninsulin 40 iu/ml Suspension for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationAgencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)
DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT
More informationIrish Medicines Board
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) REGULATIONS 2007 (S.I. No. 144 of 2007) VPA: 10823/017/001 Case No: 7001831 The Irish Medicines Board in exercise of the powers conferred
More informationMUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS 8, rue Claude Bourgelat Parc d'activités de la Grande Marche CS 70611 35306 Fougères FRANCE MUTUAL RECOGNITION PROCEDURE FOR A VETERINARY MEDICINAL PRODUCT
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF VETERINARY MEDICINAL PRODUCT HESKA PERIOceutic Gel 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each unit dose contains: 2.1 Active substance Doxycycline
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Animedazon Spray, 2.45 % w/w cutaneous spray suspension for cattle, sheep and pigs (AT, BE, BG, CZ, CY, DE, DK, EL, ES, FR,
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Human proteins g/l g/l of which human immunoglobulin at least to. 180 IU/ml 180 IU/vial
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT UMAN BIG 180 IU/ml Solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Human hepatitis B immunoglobulin. UMAN BIG 180 IU/1
More information[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Procamidor 20 mg/ml solution for injection (AT, CZ, DE, EE, ES, IT, LT, LV, NL, PT, RO, SI,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BE, CY, CZ, DE, EL, FR, HU, LU, NL, PT, SK, UK: KELACTIN 50 microgram/ml oral solution for dogs and cats DK, FI, IS, NO, SE:
More informationWHO PACKAGE INSERT. GlaxoSmithKline Biologicals FluLaval. Dossier First - Chapter 1 to 10 for WHO
77 WHO PACKAGE INSERT 11 Chapter 4_Annex 4.4-1_ WHO leaflet_en - Page 1 78 1. NAME OF THE MEDICINAL PRODUCT, suspension for injection Influenza vaccine (split virion, inactivated) 2. QUALITATIVE AND QUANTITATIVE
More informationPackage leaflet: Information for the user
8U004E Package leaflet: Information for the user DT Diphtheria-tetanus vaccine adsorbed suspension for injection Diphtheria and tetanus vaccine, adsorbed Tetanus toxoid not less than 40 IU and diphtheria
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare 9 mg/ml solution for injection/infusion
More informationIndications: For the treatment and control of fascioliasis in cattle and sheep.
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Zanil Fluke Drench 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active Substance Oxyclozanide 3.4 % w/v Excipients Methyl Parahydroxybenzoate E218 0.15 % w/v Propyl
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oxybee powder and solution for 39.4 mg/ml bee-hive dispersion for honey bees 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CaniLeish lyophilisate and solvent for suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More information